Cancer Pharmacogenomics Development, Science, Translation

More documents

Recommendations

Info

Pharmacogenomics Clinical Goals • Avoid adverse drug reactions • Maximize drug efficacy • Select responsive patients
Cancer Pharmacogenomics Challenges • Germline and/or somatic genome • Clinical trials and/or population studies • Translational and/or mechanistic studies • Funding to incorporate rapidly changing, expensive technologies • Collaboration and replication
Page 1 and 2: Cancer Pharmacogenomics Development
Page 3 and 4: Pharmacogenetics-Pharmacogenomics C
Page 5 and 6: Pharmacogenetics-Pharmacogenomics S
Page 7 and 8: Pharmacogenetics-Pharmacogenomics F
Page 9 and 10: • Low TPMT TPMT Genetic Polymorph
Page 11 and 12: Pharmacogenetics-Pharmacogenomics F
Page 13 and 14: CYP2D6 Pharmacogenetics Number of S
Page 15 and 16: Tamoxifen Pharmacogenetics No Tamox
Page 17 and 18: Cancer Pharmacogenomics • Introdu
Page 19 and 20: Cytidine Analogues Ara-C N NH 2 Gem
Page 21 and 22: Gemcitabine-AraC IC50 - Expression
Page 23 and 24: The Therapeutic Revolution Goodman
Page 25 and 26: FKBP5 Functional Characterizatoin C
Page 27: Pharmacogenomics Genomic Era Develo
Page 32: Mayo Pharmacogenomics Laboratories

Cancer Pharmacogenomics Development, Science, Translation

Create successful ePaper yourself

Delete template?

Save as template?